Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies-Reference-Cited by-同舟云学术

Predictive value of epidermal growth factor receptor expression for first-line chemotherapy plus cetuximab in patients with head and neck and colorectal cancer: Analysis of data from the EXTREME and CRYSTAL studies

Published:2013-04 Issue:6 Volume:49 Page:1161-1168
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Licitra Lisa,Störkel Stephan,Kerr Keith M.,Van Cutsem Eric,Pirker Robert,Hirsch Fred R.,Vermorken Jan B.,von Heydebreck Anja,Esser Regina,Celik Ilhan,Ciardiello Fortunato

Funder

Merck KGaA

Jim Heighway of Cancer Communications & Consultancy Ltd.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference22 articles.

1. Platinum-based chemotherapy plus cetuximab in head and neck cancer;Vermorken;N Engl J Med,2008

2. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer;Van Cutsem;N Engl J Med,2009

3. Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: updated analysis of overall survival according to tumor KRAS and BRAF mutation status;Van Cutsem;J Clin Oncol,2011

4. Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial;Pirker;Lancet,2009

5. Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: the OPUS study;Bokemeyer;Ann Oncol,2011

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Receptor-Targeted Nanomedicine for Cancer Therapy;Receptors;2024-07-03

2. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives;International Journal of Molecular Sciences;2024-02-28

3. Mechanistic and Clinical Chemoprevention;Reference Module in Biomedical Sciences;2024

4. Somatic mutation: Pharmacogenomics in oncology care;Biomarkers in Cancer Detection and Monitoring of Therapeutics;2024

5. Randomized phase II study of preoperative afatinib in untreated head and neck cancers: predictive and pharmacodynamic biomarkers of activity;Scientific Reports;2023-12-18